Bharat Biotech inks pact with Precisa Med to supply Covaxin to Brazil
Premium
The supplies of Covaxin will be prioritized for public market, through direct procurement by Brazil government
The supplies of Covaxin to private market would be based upon receipt of market authorization from Brazilian regulatory authority ANVISA
Share Via
Read Full Story
Bharat Biotech on Tuesday announced that it has signed an agreement with Precisa Medicamentos for the supply of its indigenously manufactured Covid-19 vaccine 'Covaxin' to Brazil.
The supplies of Covaxin will be prioritized for public market, through direct procurement by Brazil government, the company said in a statement.